The bioregion is from until November 13 participating at the 25th Annual International Partnering Conference BIO-Europe 2019 in Hamburg.
- The bioregion is from until November 13 participating at the 25th Annual International Partnering Conference BIO-Europe 2019 in Hamburg.
- Galicia and the North of Portugal come together to create a bioregion with international orientation.
- The bioregion that represents more tan 120 biotech companies grows at an annual average of 15%.
- This Bioregion intends to collaborate with other bioregions on merging into synergies.
November, 11. Hamburg.- The 25th Annual International Partnering Conference BIO-Europe 2019 hosts these days the presentation of the Galicia-North of Portugal Bioregion. Being geographically close, Galician and Northern Portugal companies can merge into synergies, which could not exist if they were not this close. This geographical proximity is a key factor for the birth of this bioregion. The region Galicia-North of Portugal biotechnological sector uses its progress potential in order to innovate, and entails a strategic bet on the future for all economic agents of the Bioregion.
This achievement looks forward to improving business competitiveness and consolidating the biotech and life sciences sector in the Bioregion Galicia-North of Portugal. In order to achieve this, it uses a joint roadmap based on collaboration and cooperation between agents and companies on both sides of the border.
Companies that form the Bioregion biotechnological network have several strengths: production capacity, high level of technology and innovation, scientific knowledge development, large percentage of clients from external markets, R&D international collaboration projects and fusion and complementarity with other sectors.
The Bioregion DNA is characterized by more than 120 Biotech companies, more tan 200 M€ investment in Bio R&D, and 15% above average anual growth, 16 research centres and 6 universities.
The bioregion is export-oriented and its export levels tend to rise. This is the reason why companies are frequently in the closest European countries, as France, Germany, the United Kingdom, Switzerland or the Netherlands.
The bioregion Galicia-Northern Portugal has outstanding companies like:
- Galchimia: a reference in chemical synthesis. Improving society through organic chemistry research
- Zendal: seven companies focused on the research, development, manufacture and commercialization of high added value products in the field of health
- AmsLab: one of the leaders in the quality control sector with a high level of specialisation in matrices or highly complex components
- Oncolstellae: novel small-molecule drugs in oncology and inflammatory/autoimmune diseases
- SunRock Biopharma: therapeutic antibodies against cancer, CCR9 and HER3
- Silicolife: designs optimized microorganisms and novel pathways for industrial biotechnology applications, based on computational metabolic engineering and synthetic biology approaches
- Nuada: a revolutionary hand function improving system, safe, light and small that was designed to be affordable and non-intrusive
- Stemmatters: regenerative medicine developing ground breaking biomaterials for tissue repair and regeneration
- PeekMed: a powerful 3D pre-operative planning software for orthopedic surgery
- Sword Health: the first Digital Therapist ever. Maximizing engagement and delivering superior clinical outcomes
This bioregion has born within the framework of the CT-Bio Project. CT-Bio is possible due to the combined work of the following institutions from Galicia and the North of Portugal: representative associations of the biotech industry (Bioga and P-Bio), Universities and Research centres (University of Santiago de Compostela, University of Minho and International Iberian Nanotechnology Laboratory) and the promoter entity of economic development Vigo Free Trade Zone Consortium.
CT-Bio is a european Project co-financed by the European Union.
For more information: http://ct-bio.org/bioregion/?
Contact to press:
Fuencisla Cid: +34 639 657 943 / fcid@eosa.com
